<DOC>
	<DOCNO>NCT01039584</DOCNO>
	<brief_summary>This study compare efficacy safety generic butoconazole nitrate vaginal cream , 2 % Gynazole-1 ( butoconazole nitrate ) Vaginal Cream , 2 % treatment vulvovaginal candidiasis cause Candida specie .</brief_summary>
	<brief_title>A Randomized Study Evaluating Therapeutic Equivalence Two Butoconazole Nitrate Vaginal Cream , 2 % Formulations</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Vulvovaginal</mesh_term>
	<mesh_term>Butoconazole</mesh_term>
	<criteria>Female subject , least 18 year age Presented symptomatic vulvovaginitis consistent diagnosis moniliasis Signed date informed consent Were pregnant , nursing , plan pregnancy within study participation period Had evidence bacterial , viral , protozoal infection Had hypersensitivity allergy imidazole , analogue , and/or Test Product ingredient Had medical condition , use medication , opinion investigator , could interfere conduct study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>butoconazole</keyword>
	<keyword>vulvovaginal</keyword>
	<keyword>candidiasis</keyword>
</DOC>